6-29603586-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001470.4(GABBR1):c.2843G>A(p.Arg948Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,591,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001470.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GABBR1 | NM_001470.4 | c.2843G>A | p.Arg948Gln | missense_variant | 23/23 | ENST00000377034.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GABBR1 | ENST00000377034.9 | c.2843G>A | p.Arg948Gln | missense_variant | 23/23 | 1 | NM_001470.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 151908Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000171 AC: 37AN: 216420Hom.: 0 AF XY: 0.000153 AC XY: 18AN XY: 117766
GnomAD4 exome AF: 0.000111 AC: 160AN: 1439706Hom.: 0 Cov.: 31 AF XY: 0.000115 AC XY: 82AN XY: 714468
GnomAD4 genome AF: 0.0000987 AC: 15AN: 151908Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74204
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.2843G>A (p.R948Q) alteration is located in exon 23 (coding exon 22) of the GABBR1 gene. This alteration results from a G to A substitution at nucleotide position 2843, causing the arginine (R) at amino acid position 948 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at